REPAGLINIDE 1 MG TABLET

Repaglinide
$0.0811per EA

Strength

1 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135094790

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

REPAGLINIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078555

On Market Since

1/22/2014

Pharmacological Classes

Glinide
Potassium Channel Antagonists

Price History

1W

0.0%

1M

+1.3%

3M

-2.9%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-11.9%